Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study
{{output}}
Aims: To characterize the progression patterns and analyze the efficacy of immune checkpoint inhibitors (ICIs) in unresectable, recurrent, or metastatic cholangiocarcinoma (CCA). ... ...
